Bayer and Rad AI Partner To Bring AI Radiology Solutions

Bayer, a leading pharmaceutical firm and Rad AI have declared a partnership to offer Rad AI’s advanced AI radiology operational solutions to calantic digital solution customers. In addition to Bayer's CalanticTM Digital Solutions platform, Rad AI's radiology speech recognition reporting solution, AI-driven patient follow-up management, and automated radiology impression generation technologies make it possible for more hospitals and health systems to benefit from Rad AI's generative AI capabilities.  Imaging data makes up about 90% of all healthcare data1, and the number of images keeps growing, making it harder for radiologists to work with limited resources. At the same time, the requirement to demonstrate the value of AI deployments is growing. This partnership allows Radiology suites to take advantage of operational Radiology AI applications and a scalable deployment platform integrated through one vendor.

Rad AI assists radiologists with making reports quicker by utilizing generative AI to sort out radiology reports for radiologists permitting them to focus on perusing concentrates as well as coordinating stable discoveries from earlier reports. Rad AI Omni Impressions produces modified radiology report impressions from directed discoveries, customized to every radiologist's language preferences and serving to diminishing exhaustion. The follow-up process for incidental findings is automated by Rad AI Continuity, facilitating prompt patient follow-up and potentially increasing imaging revenue for health systems.

"Rad AI and Bayer are dedicated to pioneering innovations that serve hospitals and health systems, allowing for greater access to these advanced technologies. This relationship allows for expanded use of our cutting-edge solutions in hospitals across the country," Doktor Gurson, co-founder and CEO of Rad AI.